$5.36
-0.3-5.30%
At close: -
$5.51
0.152.80%
After Hours: 7:06 PM EDT
Reshape Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Reshape Lifesciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-5.22 | $-9.28 | 43.8 % |
Sep 2023 | 2023-11-08 | $-59.16 | $-69.60 | 15.0 % |
Jun 2023 | 2023-08-07 | $-62.64 | $-103.82 | 39.7 % |
Mar 2023 | 2023-05-15 | $-90.48 | $-244.18 | 62.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $1.97M | $2.21M | -11.1 % |
Mar 2024 | 2024-05-15 | $1.94M | $2.10M | -7.43 % |
Sep 2023 | 2023-11-08 | $2.15M | $2.40M | -10.2 % |
Jun 2023 | 2023-08-07 | $2.25M | $2.61M | -13.6 % |
Reshape Lifesciences (RSLS) is scheduled to report earnings on November 26, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-3.48, which missed the estimate of $0.00.
The Actual Revenue was $2M, which missed the estimate of $2.2M.
Browse earnings estimates, EPS, and revenue on all stocks.